Riociguat for the Treatment of Pulmonary Arterial Hypertension (PAH)

Please join us for our next Pharmacy Resident Seminar presentation on Thursday, September 30, 2021, presented by UIC College of Pharmacy PGY1 Pharmacy Practice Resident, Reham Awad, PharmD.

Type of Activity: Knowledge                                                                                                                             Target Audience: Pharmacists

Time: Thursday, September 30, 2021,  12:30 pm - 1:20 pm

Fees: There is no charge for attending this activity

Location: Chicago, Room 134-1 and via Zoom

Zoom Meeting Information:
Meeting link: https://go.uic.edu/residentseminar2021-2022
Meeting number: 871 4292 0130
Password: 3Rx8KyKR
Or
Join by phone: 1-312-626-6799 (Chicago)

Learning Objectives :

At the completion of this activity, the participant will be able to:

• Discuss the trials that led to the approval of riociguat for the treatment of pulmonary arterial hypertension.
• Describe current evidence for transitioning from phosphodiesterase-5 inhibitors to riociguat maintenance therapy for the treatment of pulmonary arterial hypertension.
• Explain safety concerns and monitoring parameters associated with soluble guanylate cyclase agonists in the treatment of pulmonary arterial hypertension.

Disclosure: The speakers, planning committee members, and reviewers who contributed to this activity have no relevant financial conflicts of interest to disclose.